News
28.11.2023 news
Standardizing tissue quality: Your key to accurate early discovery insights
In precision oncology, tissue quality plays a pivotal role in maintaining data integrity. We explore the impact of standardizing tissue collection and processing on data quality, and how this helps enhance patient outcomes as well as our understanding of cancer.
Standardizing tissue quality: Your key to accurate early discovery insights Mehr erfahren21.09.2023 news
Precision therapeutics: optimizing early discovery
Precision medicine tailors therapeutics to individual patients’ diseases, and is seen as the future of clinical practice. With significant time and financial investments being made in developing therapeutics, the ultimate success of patient-data driven precision therapies hinges on three main factors: the quality of the tissue samples, the associated molecular data, and the analysis used in their development.
Precision therapeutics: optimizing early discovery Mehr erfahren28.07.2023 news
Where the medicine of the future is already being lived in the present
More than 20 years ago, Indivumed set out to create a solid database for the individualized cancer therapy of the future. Today, founder and CEO Prof. Dr. Hartmut Juhl considers himself to have made considerable progress along this path, not least thanks to his company's unique database. In an interview with Wirtschaftsforum, the passionate entrepreneur talked about the future prospects.
Where the medicine of the future is already being lived in the present Mehr erfahren24.07.2023 news
Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach
Read our at MDPI newly published paper on "Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach".
Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach Mehr erfahrenEvents
Publications and Posters
21.10.2023 poster
Poster Bischof et al. 2023 Combining cancer patient spatial transcriptomics and bulk rna-seq data to drive insights into NSCLC
Poster Bischof et al. 2023 Combining cancer patient spatial transcriptomics and bulk rna-seq data to drive insights into NSCLC Mehr erfahren09.10.2023 publication
Yuyi, H. et al. A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient Cell Death Discovery 9, 370 (2023)
Yuyi, H. et al. A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient Cell Death Discovery 9, 370 (2023) Mehr erfahren02.10.2023 publication
Yang, X. et al A primary luminal/HER2 negative breast cancer patient with mismatch repair deficiency Cell Death Discovery 9, 365 (2023)
Yang, X. et al A primary luminal/HER2 negative breast cancer patient with mismatch repair deficiency Cell Death Discovery 9, 365 (2023) Mehr erfahren03.09.2023 publication
Michalska-Falkowska et al. MDPI 2023 Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach
Michalska-Falkowska et al. MDPI 2023 Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach Mehr erfahren
VIDEOS
Indivumed Therapeutics:
Data-driven precision oncology
Introducing:
Indivumed Therapeutics, April 2023
In Focus:
The Future of Indivumed – Interview with Prof. Dr. Hartmut Juhl, Indivumed Therapeutics
In Focus:
Therapeutic target Identification – Interview with Dr. Jonathan Woodsmith, Indivumed Therapeutics
In Focus:
Clinical Network – Interview with Dr. Susanne Arbogast, Indivumed Therapeutics
In Focus:
nRavel – Interview with Dr. Jonathan Woodsmith, Indivumed Therapeutics
In Focus:
Data Depth – Interview with Dr. Jonathan Woodsmith, Indivumed Therapeutics
In Focus:
Data Quality – Interview with Dr. Jonathan Woodsmith, Indivumed Therapeutics
In Focus:
Our Vision – Interview with Dr. Jonathan Woodsmith, Indivumed Therapeutics
In Focus:
AI – Interview with John L. Marshall, MD, Georgetown University Hospital
In Focus:
Precision Oncology – Interview with John L. Marshall, MD, Georgetown University Hospital